Novo CEO pressed by Senate to chop rates of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would consider new talks with insurers concerning the checklist prices of Wegovy and copyright whenever they pledge to help keep the medicines on their formularies. Insurers will keep on https://kethek.com/